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A poly-70L/30DL-lactide (PLA70)–β-tricalcium phosphate (β-TCP) composite implant reinforced by continuous PLA-96L/4D-
lactide (PLA96) ﬁbers was designed for in vivo spinal fusion. The pilot study was performed with four sheep, using titanium cage
implants as controls. The composite implants failed to direct bone growth as desired, whereas the bone contact and the proper
integration were evident with controls 6 months after implantation. Therefore, the PLA70/β-TCP composite matrix material was
further analyzed in the in vitro experiment by human and ovine adipose stem cells (hASCs and oASCs). The composites proved
to be biocompatible as conﬁrmed by live/dead assay. The proliferation rate of oASCs was higher than that of hASCs at all times
during the 28d culture period. Furthermore, the composites had only a minor osteogenic eﬀect on oASCs, whereas the hASC
osteogenesis on PLA70/β-TCP composites was evident. In conclusion, the composite implant material can be applied with hASCs
for tissue engineering but not be evaluated in vivo with sheep.
1.Introduction
Degenerative or traumatic conditions of the cervical spine
are generally treated by anterior cervical discectomy and
fusion [1]. The highest fusion rates have been reported
with this technique when the gold standard, autograft
bone, has been used alone to replace the intervertebral disc
[2, 3].Nevertheless,thisapproachhasmajordrawbacks,thus
v a r i o u sb i o m a t e r i a l ss u c ha sm e t a l s[ 3–5], polymers [6–8],
and composites [9–12] for interbody fusion devices (IBFDs)2 International Journal of Biomaterials
are intensively studied. Metallic devices are a conventional
optionbutnotanidealoneduetoseveraldisadvantagessuch
as cage migration, subsidence, nonunions, stress shielding,
and artifacts in imaging methods [11]. Instead, polymer-
ceramic composites are often utilized since the mechanical
properties can be optimized according to a speciﬁc appli-
cation [9, 13]. The polymer component provides strength,
formability, and biodegradability, whereas the ceramic com-
ponent provides bioactivity for the composite [13, 14].
The biodegradable polymers from the poly(α-hydroxy
acid) family especially have been extensively investigated for
spinal applications due to their excellent biocompatibility
[15]. One of the most popular polylactides, poly-70L/30DL-
lactide (PLA70), has been widely used for various applica-
tions, such as guided bone regeneration [16] and to repair
large bone defects of the orbital wall [17] in addition to
spinal defects. Furthermore, it has been applied successfully
f o rb o n ef r a g m e n tﬁ x a t i o n ,a sw e l la sf o rf e m o r a la n dr a d i a l
headfractures[13,18,19].EspeciallythecapabilityofPLA70
to tolerate sterilization without signiﬁcantly impairing its
mechanical properties [13] enables its versatile use in ortho-
pedic applications. Importantly, the degradation products of
PLA70 pins have been demonstrated in vitro and in vivo not
to lead to any clinically relevant inﬂammation of either joint
or lymph nodes [19].
Among bioactive components, β-tricalcium phosphate
(β-TCP) has been used for decades in various orthopedic
applications due to its osteoconductive and biodegradable
nature [20]. Although β-TCP has several favorable proper-
ties, it has poor mechanical properties and hence an elevated
riskoffracture.Itisthereforemoresuitableasaﬁllermaterial
than to be used alone in load-bearing applications of major
skeletal defects [14].
Although several intercorporal polymer-ceramic com-
posites have been studied in spinal fusions, the ideal bioab-
sorbable weight-bearing fusion device that would promote
fusion without causing foreign body reactions or biome-
chanical failures is yet to be found. In our study, we wanted
toimproveapreviouslyintroducedPLA70/β-TCPcomposite
fusioncage[21],enhanceitspotentialossiﬁcationproperties,
and increase its mechanical stability by incorporating cir-
cumferentialpoly-96L/4D-lactide(PLA96)continuousﬁbers
around the composite. The primary aim of this study was to
evaluatetheinvivoboneformationabilityofthenovelfusion
cage in ovine spinal fusion model. To assess the osteogenic
potential and ensure the biocompatibility of the PLA70/β-
TCP matrix material, we performed in vitro assays using
human and ovine adipose stem cells (hASCs and oASCs).
2.MaterialsandMethods
2.1. Composite Implant Manufacturing for In Vivo and In
Vitro Studies. The in vivo composite implants consisted of
3d i ﬀerent bioabsorbable raw materials: PLA70 (Boehringer
Ingelheim GmbH, Ingelheim am Rhein, Germany) was used
as a matrix polymer of the cage body, PLA96 (PURAC
Biochem, Gorinchem, The Netherlands) as a reinforcement
ﬁber material, and β-tricalcium phosphate (β-TCP, Plasma
Biotal Ltd., Derbyshire, UK) as an osteoconductive ﬁller in
the PLA70 matrix.
The matrix polymer PLA70 and 30wt% of β-TCP
were ﬁrst melt mixed using a 20mm twin screw extruder.
Preforms were machined out of the compounded matrix
polymer rod containing 30wt% of β-TCP. Reinforcing ﬁbers
madeofPLA96weremeltprocessedusingthesameextrusion
equipmentandsubsequentlyoriented to0.3mmthickﬁbers.
Further, 2 meters of reinforcing ﬁbers were wound around
the preform. The hollow interior was machined after com-
pression molding to the ﬁnal implant shape including sharp
ridges towards the vertebral endplates to ensure suﬃcient
primary ﬁxation. Due to this manufacturing technique,
ceramic particles are not covered by the matrix polymer
and are free to interact with surrounding ﬂuids. (Figures
1(c), 1(d),a n d1(e)). The size of the implant for the in vivo
study was 14mm × 16mm with a lordotic 5◦ angle, and
three diﬀerent heights 5, 6, and 7mm were used in order to
accommodate diﬀerent disc heights of the study animals.
The in vitro composite samples consisted of 70wt% of
PLA70 and 30wt% of β-TCP. The samples were manufac-
tured similarly as the in vivo matrix composite implants. A
custom made mold in the compression molding was used to
ensure the uniformity of each sample. The polystyrene (PS)
cellculturewellsof24-wellplates(NunclonMultidisk,Nunc,
Roskilde, Denmark) were used as reference. The size of both
composite samples and PS wells was equal (ø 15mm).
Both in vivo composite implants and in vitro composite
samples were manufactured by Bioretec Ltd. (Tampere,
Finland) and gamma sterilized by Gamma-Service Produk-
tbestrahlung GmbH (Radeberg, Germany) using 17.5kGy
irradiation.
2.2. Control Implants and Other Hardware Used for the In
Vivo Study. CeSpace Titanium Plasmapore pure titanium
coated cages (Aesculap AG/Co. KG Tuttlingen, Germany)
sized 14mm × 11.5mm with a lordotic 5◦ angle were used
as control implants. The height of the implant was chosen
according to the disc height ranging from 5 to 7mm in 1mm
increments. For the primary stability through cranial and
caudal ﬁxation crown one-third tubular plate 3.5w/collar,
5 holes, length 64mm (SYNTHES Oberdorf, Switzerland),
and cortex screws 3.5mm diameter of 16–20mm length
(SYNTHES) were used in both study groups. One plate and
two screws were applied for each ﬁxation.
2.3. In Vivo Experiment in an Ovine Anterior Spinal
Fusion Model
2.3.1. Implantation Procedure and Followup. Ethical consent
for the study protocol was given by the Animal Ethical
Committee of the Provincial State Oﬃce of Western Finland
(permit no. 1666/06), and all procedures were carried out in
accordance with the guidelines of the local Animal Welfare
Committee. Four 3-4-year-old sheep obtained from a class
MV3breeder(Reipelt,Finland)weighing49–78kgwereused
in this pilot study. The pilot animals were randomized to
receive either the control implant (n = 2) or the compositeInternational Journal of Biomaterials 3
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(d) (e)
Figure 1: (a) CeSpace Titanium Plasmapore cage serving as a control implant for the in vivo study. (b) Poly-(70L/30DL)-lactide-ﬁber-
reinforced β-tricalcium phosphate (β-TCP) composite cage (PLA70/β-TCP) for the in vivo study. (c), (d), and (e) Scanning electron
micrograph (SEM) images of PLA70/β-TCP composite matrix by magniﬁcations of 35X, 100X, and 500X, respectively, showing the ceramic
particles in the surface of the polymer matrix without any isolating ﬁlm.
implant (n = 2). Intramuscular (i.m.) premedication with
midazolam was used. Fentanyl, ketamine, and propofol were
administered intravenously (i.v.) for induction anesthesia,
andpropofolinfusionwasusedtomaintainanesthesia.Local
xylocaine was sprayed into the larynx just before intubation.
Amoxicillin 1g was given before surgery i.v.
Under strict sterile surgical conditions, each sheep
underwent surgery for a single-level discectomy and anterior
fusion C3/4. For autograft harvesting, an incision of 8cm
was made over the sternum. After partial reﬂection of the
skin and subcutaneous tissues, using a 5mm Kerrison punch
(Aesculap AG/Co. KG Tuttlingen, Germany), 0.5cm3 of
autogenous cortical and cancellous bone was removed. The
sternal incision site was closed using resorbable subcuta-
neous sutures Saﬁl 2.0 (Aesculap, Corporate Parkway Center
Valley, PA, USA) and stainless steel skin staples Appose ULC
stapler (Autosuture/ Tyco Healthcare, Hampshire UK).
Ventral exposure and discectomy were then performed.
The level of interest was veriﬁed under ﬂuoroscopy. A mid-
line ventral incision was made, and the paired sternohyoid
and sternomastoid muscles were separated on their midline.
The longus colli muscle was incised in the midline, and
the intervertebral disc C3/C4 was exposed and a complete
discectomy was performed. The endplates were removed
down to bleeding bone, using a high-speed burr. The hollow
interior of the implant was then packed with autogenous
bone graft harvested from the sternum and implanted under
ﬂuoroscopic imaging. The anterior stabilization with a one-
third tubular plate and cortex screws was then performed in
order to prevent extrusion of the implants due to excessive
extension movements. Primary stability after implantation
was ensured through the cranial and caudal ﬁxation of
the implant and by the anterior plate and screw ﬁxation.
Secondary stability was achieved through bony ingrowth
into the increased surface area resulting from the control
implants’ Plasmapore coating.
The longus colli muscles aponeurosis, fascia, and sub-
cutis were then closed in layers and the wounds were covered
with a topical antibiotic powder, Bacibact (Bacitracin 250IU
and Neomycin 5mg, Orion, Finland) and liquid band-aid
(Hansaplast, Hamburg, Germany).
Postoperatively, the animals received 0.01mg/kg of
buprenorphine i.m. 4 times daily for the ﬁrst 2 days, and
for the next 2 days twice a day. The health of animals was
monitored twice daily throughout the study. The sheep were
allowed ad libitum activity for the remainder of the followup.
The pilot animals were sacriﬁced 6 months after the surgery.
Euthanasia was achieved by exsanguination in anesthesia,
andthespinesegmentsofinterestwereharvestedandcleared
of soft tissue.
2.3.2. Digital Radiograph. Standard anterior-posterior (A-
P) radiographs of the spine segments were taken after
surgery and before sacriﬁce on the digital image plates4 International Journal of Biomaterials
(Fuji IP cassette, Fuji Photo Film Co. Ltd., Japan) using a
standard stationary X-ray unit (Philips, Holland). All sheep
underwent computed tomography (CT) of the dissected
bone block of the cervical spine using a 64-detector row CT
system (Somatom Sensation 64, Siemens Medical Imaging,
Erlangen, Germany). CT technical parameters included
140mAs, 120kV and 3 reconstructed image sets: axial slices
with 1mm section thickness and 1 increment with sharp
kernel, coronal slices with 0.4mm section thickness and 0.2
increment with sharp kernel, and sagittal 0.4mm section
thickness and 0.2 increment with sharp kernel. The matrix
was 512 × 512 in all slice sets.
2.3.3. Histology. The C3/C4 motion segments were ﬁxed
for 2–4 weeks in 10% normal buﬀered formalin followed
by dehydration in ascending concentrations of ethanol.
Clearing was performed in xylene for 4 days, and samples
were then embedded undecalciﬁed in isobornylmethacrylate
(Technovit 1200 VLC, Kulzer, Algol, Germany).
Specimens were cut in the sagittal plane into approxi-
mately 5μm thick sections with a Leica heavy duty sliding
microtome (Leica, Wetzlar, Germany). The sections were
then stained with hematoxylin and eosin (H&E) and with
modiﬁed van Gieson stains. Histologic sections were imaged
using an Olympus B51 virtual microscope with a U-CMAD3
camera attached (Olympus Optical Co. Ltd, Tokyo, Japan).
The foreign body reaction was graded according to the score
of Hoﬀmann [22].
2.4. In Vitro Experiments
2.4.1. ASC Isolation, Culture, and Seeding. hASCs from 2
donors were isolated from adipose tissue obtained from a
surgical procedure at the Department of Plastic Surgery,
Tampere University Hospital. oASCs from 2 sheep were
provided by the Faculty of Medicine, University of Tampere.
The ASC isolation from the tissue samples was conducted
in accordance with the Ethics Committee of Pirkanmaa
Hospital District, Tampere, Finland.
The minced tissue samples were digested with col-
lagenase Type I (1.5mg/mL; Invitrogen, Paisley, UK) as
previously described [23, 24]. Isolated ASCs were cultured
and expanded in T-75cm2 ﬂasks in maintenance medium
consisting of Dulbecco’s Modiﬁed Eagle Medium/Ham’s
Nutrient Mixture F-12 (DMEM/F-12 1:1 1x; Invitro-
gen), 10% fetal bovine serum (FBS, Invitrogen), 1%
L-glutamine (GlutaMAX I, Invitrogen), and 1% antibi-
otics/antimycotic (100U/mL penicillin, 0.1mg/mL strepto-
mycin, and 0.25mg/mL amphotericin B; Invitrogen) [25–
27]. As soon as the cells had reached conﬂuence, they
were stored at −70◦C and thawed for the experiments.
The immunophenotype of each ASC line was veriﬁed using
ﬂow cytometry (FACSAria, BD Biosciences, Erembodegem,
Belgium) [28].
Cells of passages 3 to 4 were used for all experiments.
Each composite sample was pretreated with maintenance
medium for 48h at 37◦C in 24-well plates (Nunclon
Multidisk, Nunc). The samples were seeded with 25,000
cells in a ﬁnal culture volume of 1mL of maintenance
medium.
2.4.2. ASC Attachment and Viability. Cell attachment and
viability were evaluated qualitatively using live/dead-viabil-
ity assay (Molecular Probes, Eugene, Ore, USA) at 7, 14,
and 28d time points. CellTracker Green 5-chloromethyl-
ﬂuoresceindiacetate(CMFDA);MolecularProbesandethid-
ium homodimer-1 (EthD-1; Molecular Probes) were utilized
to dye viable cells (green ﬂuorescence) and dead cells (red
ﬂuorescence), respectively [25–27].
2.4.3. Cell Proliferation and Quantitative Analysis of Alkaline
Phosphatase Activity. On the day of the analysis, 250μL
of 0.1% Triton-X 100 buﬀer (Sigma Aldrich, St. Louis,
MO, USA) was added to each well and thoroughly sus-
pended. The well-plates were stored at −70◦Ca tl e a s t
over night to lyse the cells. The DNA content of ASC
composite and PS samples was measured after 7, 14, and
28d culture periods using a CyQUANT Cell prolifera-
tion assay kit (Molecular Probes—Invitrogen) according
to manufacturer’s protocol and as earlier described [29].
The ﬂuorescence was measured with Victor 1420 Multil-
abel Counter, (Wallac, Turku, Finland). The quantitative
alkaline phosphatase (ALP) measurement was performed
at 14 and 28d time points according to the Sigma
ALP procedure (Sigma Aldrich) [26] with minor modi-
ﬁcations. Quantitative ALP activity results were normal-
ized to the total DNA amount measured from the same
lysates.
2.4.4. Mineralization. Von Kossa staining was used to
qualitatively estimate the mineralization nodule formation
to demonstrate the osteogenic diﬀerentiation of ASCs. A
previously described method [30] was used with minor
modiﬁcations. Brieﬂy, the cultures were ﬁxed with 4%
paraformaldehyde for 2min, followed by a double wash
with distilled water. A 5% silver nitrate (AgNO3)s o l u t i o n
was added to the wells, and the plates were incubated
under an ultraviolet (UV) lamp for 60min without covers.
AgNO3 was removed, the cultures were washed with distilled
water, and the plates were photographed with a digital
camera.
2.4.5. Statistical Analysis of the In Vitro Results. The statis-
tical analyses were performed with SPSS, version 14. The
data was presented as mean ± standard deviation (SD)
for both quantitative analyses. Equal variance assumption
was checked by Levene’s test. All statistical analyses were
performed at the signiﬁcance level P<0.05 using one-
way analysis of variance (ANOVA) or t-test. Bonferroni post
hoc correction for multiple corrections was used. The eﬀects
of diﬀerent culturing times (7 versus 14 versus 28d) and
sample materials (composite versus PS) were evaluated for
both species. Samples were regarded as independent at each
time point.International Journal of Biomaterials 5
3. Results
Thepostoperativehealingwasuneventfulexceptfor1animal
from the composite implant group that suﬀered ORF virus
disease. Due to weakness of the hind legs, the animal had to
be euthanized 5 months after surgery.
3.1. Radiographic Evaluation of Fusion. Lateral plain X-rays
showed well-aligned vertebrae in all study groups (Figures
2(a)–2(c)). CT images of the composite implant group
showed fragmentation in one implant and one anterior
coronal fracture line in the other implant, but no migration
of the fragments. No continuous bone growth through the
implant was observed, and no implant to bone fusion was
found (Figures 2(e)-2(f)). There was a marked resorption
of the autograft. Sclerosis of the endplates was observed
suggesting malunion. No signs of osteitis were seen in
any of the study groups. In the control implant group an
advanced fusion was seen inside the implant, with trabecular
orientation and almost complete integration of the autograft
to the adjacent vertebra (Figure 2(d)).
3.2. Histomorphological Studies. Histomorphological analy-
sis of both groups at 6 months supported the ﬁndings of
the radiographic examinations. Histologically, a mild foreign
body reaction developed in the composite implant group,
accordingtothescoreofHoﬀmann[31].Therewasamarked
resorption of the autograft and multinucleated foreign body
macrophages inside the implant. A dense ﬁbrotic capsule
surrounded the composite implant, and no bone contact was
found (Figures 2(h)–2(i)). Furthermore, no signs of acute
infection were found. One of the implants was fragmented
at 6 months followup, but no migration of fragments
was observed. The endplates were dense, and the expected
trabecular orientation at the fusion site had disappeared
suggesting malunion.
After 6 months, there was an advanced interbody fusion
in the control group seen as bone ingrowth through the
implant. Improved alignment in the vertical and horizontal
trabeculae was observed. There was a direct bone contact at
the bony endplates to the implant. There were signs of dark
ﬁne granules surrounding the implant, which were visible in
Polaroid light suggesting metallosis (Figure 2(g)).
3.3. In Vitro Experiments
3.3.1.ASCCharacterization. Theﬂowcytometricanalysison
ASCs demonstrated expression for markers substantiating
mesenchymal origin of cells and showing low or lack
of expression of markers suggesting hematopoietic and
angiogenicoriginofcells(Table1).Thecharacterizationdata
comply with existing results on hASCs [23, 28, 32–35]a n d
oASCs [36–38].
3.3.2. Cell Viability. Microscopic observations revealed that
after 7 days of culture, the ASCs of both species had normal
morphology and they were well attached to the composite
samples and PS (Figure 3). The majority of the cells of
both species were viable, and the number of dead cells was
low. hASCs were homogenously spread on both composite
samples and PS. By contrast, oASCs tended to detach more
fromthecompositesurfacesatalltimepointsthanhASCs.In
addition, the number of oASCs was estimated to be higher
on PS than composite samples. The high proliferation rate
of oASCs and the limited growing space eventually led to
complete detachment of oASCs at 28d in some PS wells as
shown in Figure 3.
3.3.3. Cell Proliferation and Osteogenic Diﬀerentiation. The
number of ASCs present on both samples was assessed
quantitatively using the CyQUANT Proliferation method
(Figure 4(a)), which is based on the relative absorbance
values of the amount of DNA. The number of oASCs
was higher at each time point compared to the hASCs
on both materials. In addition, the number of hASCs
was signiﬁcantly higher on PS compared to the compos-
ite samples only at the 7d time point (P<0.001),
whereas the number of the oASCs was higher on the
PS during the whole culture period. This diﬀerence was
signiﬁcant at the 7 (P<0.01) and 14d time points
(P = 0.008). Further, the number of hASCs had increased
signiﬁcantly only between the 7 and 14d time points on
both materials (P<0.01). The same phenomenon was
seen with oASCs, but only on composite samples (P<
0.01).
According to the ALP activity analysis, oASCs did not
show any signs of osteogenic diﬀerentiation. The normalized
ALP activity of hASCs increased over time on PS (Fig-
ure 4(b)). On the composite, the increase in ALP activity
was signiﬁcant between the time points of 14 and 28d (P =
0.004). The relative ALP activity of hASCs was higher on
composite at 28 day, than the PS, but the diﬀerence was not
statistically signiﬁcant.
The von Kossa staining demonstrated that the PS had
no eﬀect on the mineralization of ASCs from either of
the species at any time point (Figure 5). The hASCs
mineralized on the composites, veriﬁed by the dark staining
of granules. However, there was no diﬀerence between the
time points. The staining of hASCs was more intensive
comparedtooASCs thatonly demonstrateda minor staining
result.
4. Discussion
This study evaluated the in vivo bone formation eﬃcacy of
a PLA96-ﬁber-reinforced PLA70/β-TCP composite cage in a
head-to-head comparison with a titanium cage that is widely
used in clinical practice. The in vivo model chosen for this
project was the ovine cervical fusion and discectomy model
due to its wide use in spinal studies [8, 31, 39, 40]. Sheep
continue to be among the most popular animal models for
orthopaedic research due to their similarities to human,
especially weight, size, joint structure, and bone/cartilage
regenerative process [41].
Clinical evidence exists showing that diﬀerent PLA/β-
TCP composites are biologically safe and that they may be6 International Journal of Biomaterials
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Figure 2: (a–c) Lateral plain X-rays showing aligned vertebrae at 6-month time point ((a) for control implant and (b)-(c) for composite
implants). (d) Sagittal CT at the center of the control implant shows an advanced fusion. (e) Sagittal CT image shows no implant to bone
contact or fusion of the adjacent vertebral bodies of the composite implant. (f) Sagittal CT image at the centre of the composite implant
showed fragmentation of the implant but no migration to the spinal canal and malunion of the vertebras. (g) Hematoxylin and eosin (H&E)
staining of a sagittal section at the centre of the control implant shows bone ingrowth through the implant and signs of dark ﬁne granule
surrounding the implant suggesting metallosis. (h)-(i) A dense ﬁbrotic capsule and a mild foreign body reaction surrounded the composite
implants, and no bone contact was found.
feasible alternatives as materials for bioabsorbable spinal
fusion implants [10, 42–44]. Accordingly, the composite
implant used in this study has very similar modulus of
elasticity to that of the trabecular bone and is therefore a
beneﬁcial choice with regard to stress shielding. Along with
material resorption, additional load is transferred to the
developing mass.
Studies have shown higher fusion grades using osteoin-
ductiveagents,suchasbonemorphogeneticprotein2(BMP-
2) instead of autograft bone [7]. In this study, we attemptedInternational Journal of Biomaterials 7
Table 1: Phenotypic characterization of human (hASC) and ovine (oASC) adipose stem cells by ﬂow cytometric analysis of 10,000 cells.
Data are presented as mean ± standard deviation (SD).
Surface protein Manufacturer hASC expression (mean ± SD) oASC expression (mean ± SD)
CD14 BD 5.4 8.0 ± 2.4
CD19 BD 1.5 1.2 ± 0.1
CD34 IT 4.3 ± 0.9 23.6 ± 14.5
CD45 BD 1.1 ± 1.2 9.3 ± 4.2
CD105 RD 87.3 ± 11.4 30.3 ± 7.2
CD117 MB Not analyzed 0.5 ± 0
HLA-DR IT 0.5 1.8 ± 0.3
BD: BD Biosciences, Erembodegem, Belgium; IT: Immunotools GmbH Friesoythe, Germany; RD: R&D Systems Inc., Minn, USA; MB: Miltenyi Biotech,
Bergisch Gladbach, Germany; Sigma: Sigma, St. Louis, Mo, USA; HLA-DR, major histocompatibility class II antigen.
Human
PLA/β-TCP PS
2
8
d
1
4
d
Sheep
PLA/β-TCP PS
7
d
Figure 3: Representative images of viable (green ﬂuorescence) and dead (red ﬂuorescence) adipose stem cells (ASCs) attached to composite
and polystyrene (PS) samples. Scale 100μm.
to investigate material properties and chose to use auto-
graft ﬁller in both cohorts. Moreover, anterior plating is
mandatory in the ovine model, thus making the attempted
fusionsiteevenmorerigid.Asseveralclinicalstudiessuggest,
this leads to increased fusion and reduced failure rates,
particularly in multilevel procedures [45, 46]. Nevertheless,
the present study yielded poor results in ossiﬁcation of
the composite implant in an ovine fusion model, whereas
the control implant yielded a remarkably better ossiﬁcation
of the vertebrae. This result was clear, although we acknowl-
edge that the study was limited by the small number of an-
imals and time points.
One of the possible causes for the failure was the pre-
mature degradation of the composite implant as indicated
by the malunion detected in the radiographic examination.
For the same reason, the composite implant did not provide
suﬃcient structural support to allow fusion of the treated
segment. The poor osseous integration of the composite
implant itself would predispose to pseudoarthrosis by allow-
ing inordinate movement in the segment. The single anterior
plating used in this study would not provide suﬃcient
rigidity to fuse the segment; instead, the primary task was to
avoid extrusion of the implant by eliminating the excessive
extension of the treated segment. A mild foreign body
reaction was observed in the composite implant group, but it
was not considered a reason for the malunion. Even though
a dense ﬁbrotic capsule had developed around the composite
implant, it had formed secondarily to the malunion. In
addition, macrophages were detected inside the implant,
which was conceived as a sign of autograft resorption in
the inner site of the composite. As a comparison, Kandziora
et al. [11] studied the composite fusion cage of polymer-
calcium phosphate, which showed even higher level of for-
eign body reaction by the Hoﬀman grade than in this study8 International Journal of Biomaterials
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Figure 4: (a) Relative DNA content of adipose stem cells cultured for 7, 14, and 28d on diﬀerent materials measured with CyQUANT
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Figure 5: Von Kossa staining of human and ovine adipose stem cells at 14 and 28d time point. Scale 75mm.
and superior biomechanical properties compared to tri-
cortical bone, though not interfering the formation of
bony union in a sheep cervical spine fusion model. These
results further suggest that the foreign body reaction cannot
explain the malunion in this study. The degradation time
of the composite implant could further be increased to
provide a longer safety margin if osseous union formation
is retarded. It is, however, clear that osseous union is of
the utmost importance for this type of ﬁxation and longer
degradation time most likely does not yield better outcome,
just failure at a later phase. In order to facilitate fusion
and provide suﬃcient structural support, slightly slowerInternational Journal of Biomaterials 9
degrading polymers, such as PLA96 as matrix and poly-L-
lactide (PLLA) ﬁbers, could be chosen for longer strength
retention time. In the ovine model, one has to take into
account that the ovine body temperature is three degrees
higher than that of humans resulting in a remarkably higher
degradation than suggested by calculations based on the
Arrhenius equation. With respect to the composite material,
both in vivo and in vitro composites were machined and
subsequently compression molded in precisely the same way
leading to uniform surface structures without any isolating
polymer ﬁlm, which would have hindered the bioactive β-
TCP component from being at the surface.
To further ascertain why the ossiﬁcation of the com-
posite implants was unsuccessful, in vitro biocompatibility
and osteoconductivity assays with ASCs from both human
and sheep were performed. We used ASCs over osteoblasts to
evaluate the capability of β-TCP in inducing osteogenic dif-
ferentiation of these mesenchymal stem cells. The osteogenic
potential of hASCs is well characterized from earlier studies
[47–49], but it has not been extensively studied with oASCs.
However, the osteogenic diﬀerentiation potential of ovine-
derived adult stem cells has been veriﬁed: Rhodes et al.
with ovine bone-marrow-derived mesenchymal stem cells
(bMSCs) when cultured in 3D hyaluronic scaﬀolds [50]a n d
Niemeyer et al. with oASCs when diﬀerentiated in vitro
without any biomaterial [51]. In both studies, the cells were
treated with osteogenic diﬀerentiation factors during cell
culture. It should be noted that no osteogenic medium was
used in our study, thus only the osteogenic eﬀect of the
composite material was evaluated.
In the in vitro part, we chose to focus on PLA70/β-TCP
matrix as it was considered the most important component
of the composite implant with regard to bone formation. PS
was used for in vitro assessment control to better evaluate
standard cellular behavior. The in vitro studies showed that
there was no diﬀerence between hASC and oASC viability
on the composite samples and PS as indicated by the
small number of dead cells and normal attachment on the
surfaces. Conversely, the proliferation rate of oASCs was
notably higher than that of hASCs, which partly led to the
detachment of oASCs due to the lack of growing space. On
the other hand, the number of oASCs was greater on PS at
each time point, whereas the hASCs grew equally on both
PS and composite. The osteogenic diﬀerentiation of hASCs
was veriﬁed on composite samples, as detected by the ALP
activity measurement and the von Kossa staining. This result
was consistent with our earlier study, where we showed that
the PLA/β-TCP composite scaﬀolds enhanced the osteogenic
diﬀerentiation of hASCs over the plain PLA scaﬀolds [27].
Interestingly, the von Kossa staining of oASCs demonstrated
a weak mineralization result, whereas the PLA70/β-TCP
matrix failed to induce the osteogenic diﬀerentiation of the
oASCs according to the ALP activity measurement. Our
results suggest that the PLA70/β-TCP does not support the
osteogenic diﬀerentiation of ovine mesenchymal stem cells
derived from adipose tissue. Consequently, it may partly
explain the unsuccessful osseointegration results obtained in
theinvivostudy.Thisconclusion,however,shouldbefurther
veriﬁed with other mesenchymal stem cells.
In a clinical perspective of bone tissue engineering ap-
plications, autologous cells are the best choice, also for pro-
ducts that involve scaﬀolding. It is important to note that
if similarities or diﬀerences between ASCs from diﬀerent
species remain unknown, the information about the cellular
characteristics cannot be exploited for an ideal preclinical
study setup. Given such knowledge, it is possible to choose
a suitable animal model for each bone defect application
treated by tissue engineered constructs and subsequently
evaluate the usability of autologous ASCs.
5. Conclusions
This study failed to demonstrate the in vivo bone formation
capabilityofthePLA70/β-TCP/PLA96compositefusioncage
in the chosen ovine model. According to the in vitro results,
the PLA70/β-TCP composite matrix material induced only a
weak osteogenic response on oASCs, whereas the osteogenic
eﬀect of the material on hASCs was strong.
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